Stock data
China Pharma Holdings, Inc. (CPHI)
China Pharma Holdings, Inc. (CPHI) reported revenue of US$4.14M and net income of -US$3.19M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$4.14M | -US$0.13M | -US$3.24M | -US$3.19M | — |
| 2024 | US$4.53M | -US$1.99M | -US$4.59M | -US$4.74M | — |
| 2023 | US$7.01M | -US$0.28M | -US$2.75M | -US$3.08M | — |
| 2022 | US$8.10M | -US$0.49M | -US$3.55M | -US$3.97M | — |
| 2021 | US$9.64M | US$0.35M | -US$2.86M | -US$3.40M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.95M | -US$1.46M | — |
| 2026-03-31 | US$0.98M | -US$1.14M | — |
| 2025-12-31 | US$1.23M | -US$1.22M | — |
| 2025-09-30 | US$0.76M | -US$0.65M | — |
| 2025-06-30 | US$1.03M | -US$0.53M | — |
| 2025-03-31 | US$1.14M | -US$0.79M | — |
| 2024-12-31 | US$1.13M | -US$1.22M | — |
| 2024-09-30 | US$1.10M | -US$1.12M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.